Back to results
CompletedPhase 3

Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)

NCT04029480

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

The University of Alabama at Birmingham ( Site 2207)

Birmingham, Alabama, United States

+103 additional locations

View on ClinicalTrials.gov